Alnylam Q2 Net Sales $1.17B; Lowers 2026 TTR Revenue Guidance
Alnylam achieved Q2 2026 net product revenues of $1.17 billion, but lowered its full-year TTR net product revenue outlook, citing learnings from the ATTR-CM market launch.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Alnylam achieved Q2 2026 net product revenues of $1.17 billion, but lowered its full-year TTR net product revenue outlook, citing learnings from the ATTR-CM market launch.
Replimune Group filed a Biologics License Application for RP1 combined with nivolumab to treat advanced cutaneous melanoma following anti-PD-1 failure. The filing relies on a singl…
Piper Sandler achieved record first-half revenues driven by advisory and brokerage sectors. The firm also announced a quarterly dividend of $0.20 per share along with leadership ch…
Institutional holdings report (13F-HR) filed by 13F-HR/A - Cambridge Investment Research Advisors, Inc. (0001419186) (Filer).
Vericel reported Q2 2026 total revenue of $77.5 million with strong growth in both MACI and Burn Care segments. The company raised full-year 2026 revenue guidance and approved a $2…
BGC Group reported record Q2 revenues of $846 million driven by broad-based growth across asset classes. The strong performance included a new all-time high for its FMX UST market …
Uniti Group Inc. reported a Q2 2026 net loss of $155.9 million with revenue and Adjusted EBITDA reaching $909.7 million and $357.1 million, respectively. The company highlighted re…
UFP Industries released second quarter results through June 27, 2026, showcasing strengths in its packaging, construction, and零售 segments. The company is driving growth with new te…
Marcus Corporation reported its highest Q2 net earnings and revenue since the pandemic, driven by strong performance at Marcus Theatres and Marcus Hotels & Resorts. This significan…
Evommune initiated a Phase 2b trial for EVO756 in migraine prophylaxis. This offering a new oral therapeutic option for patients not responding adequately to current treatments. Th…
Freddie Mac reported a 61% increase in Q2 2026 net income to $3.8 billion driven by credit reserve releases. The entity also supported financing for 439,000 households.
IDA reports Q2 2026 net income of $102.6M ($1.79/share) and hikes its full-year 2026 earnings guidance range to $6.30-$6.45 per share, driven by customer growth and rate changes.
Institutional holdings report (13F-HR) filed by Saudi Central Bank.
Belden delivered record second quarter revenue and orders driven by robust demand and the integration of RUCKUS Networks, with strong guidance for the current period.
Euronet reported quarterly revenue growth of 3% and strategic digital accelerator momentum, though operating income and adjusted EBITDA decreased year-over-year.
Sirius XM reported a 1% revenue increase to $2.16 billion and higher net income and adjusted EBITDA, raising its full-year financial outlook and repaying debt.
Civeo reported Q2 2026 revenues of $180 million and net loss of $2.5 million. The company secured $115 million in convertible notes to invest in growth initiatives.
The company reported record revenue and block trading volumes amid continued strategic progress. Later in the day, it announced it is being acquired by Intercontinental Exchange fo…
Saia reported a 17.1% revenue increase and record operating results, driven by volume and pricing optimization, along with significantly improved cash flow and reduced debt.
Marketaxess Holdings has entered into an agreement to be acquired by Intercontinental Exchange in a strategic move to integrate the electronic trading platform services into the IC…